In conclusion, we developed and validated a novel fusion‐induced asymmetric transcription assay‐based reverse transcription droplet digital PCR system with reliable highly clinical sensitivity, specificity, and accuracy for ALK rearrangement detection on FFPE samples from NSCLC. The gene discussed is ALK; the disease is non-small cell lung carcinoma.